Catalyst Wire Dossier Catalyst Wire Dossier

Agaricus blazei Murill

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Agaricus blazei Murill, covering 2020-10-08 to 2020-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) [Phase 2, Phase 3]

See pricing